跳至主要内容
临床试验/JPRN-UMIN000016612
JPRN-UMIN000016612已完成未知

AFIRE Study: Atrial Fibrillation and Ischemic events with Rivaroxaban in patiEnts with stable coronary artery disease Study - AFIRE Study

Japan Cardiovascular Research Foundation0 个研究点目标入组 2,200 人开始时间: 2015年2月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
2,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients who are contraindicated for rivaroxaban 2)Patients who are contraindicated for aspirin, thienopyridine derivatives (clopidogrel or prasugrel) 3)Patients who underwent PCI, including POBA, in the past one year 4)Patients who are going to undergo revascularization 5)Patients who have a past history of stent thrombosis 6)Those who are going to undergo invasive surgery (excluding digestive endoscopy and biopsy) 7)Patients who have active tumors 8)Patients who have poorly-controlled hypertension (systolic blood pressure at hospital admission based on two or more measurements: 160 mmHg or more) 9)Patients who cannot discontinue treatment with antiplatelet drugs (the physician in charge will make a decision on the basis of the lesion shape, lesion site and type of stents.) (10)Patients judged as inappropriate for this study by investigators Contraindicated for rivaroxaban (1)Unstable CAD (2)Patients with a past history of stent thrombosis (3)Patients judged as inappropriate for this study by investigators

研究者

相似试验